Curapath

Advanced-therapyAccepting projects

Leading CDMO | Polymers, Lipids and Non-Viral Nano Carriers

Paterna, SpainEurope2 sitesEst. 2013 · 13yWebsite

Request a proposal Post a project Open roomCompare

Overview Capabilities Capability matrix Technologies Regulatory & quality Project history Scientific team

Capabilities & focus

Process-development services

Custom synthesisBioconjugationFormulation developmentAnalytical method developmentGMP manufacturing

Molecule types

mRNAPolymer-drug conjugate

Therapeutic areas

Oncology

Formulation

LNP encapsulation

Technology platforms

Lipid nanoparticles (LNPs)targeted lipid nanoparticles (tLNPs)polymer nanoparticles (PNPs)PLGA-based systemspolyaminoacids (polysarcosinepoly-L-lysinepoly-L-glutamic acidpoly-L-argininepoly-L-ornithine)shielding lipids and polymersPEG alternativesionizable lipids and cationic polymersand polymer-drug conjugates. Stated payloads supported: mRNAsiRNAsaRNAplasmid DNAproteinspeptidesgene editing systemsvaccines and small molecules.

CUR

Curapath

Process development org · Spain

Post a project Request a proposal

Live record · illustrative seed data · scores deterministic, rules-based — not AI. Not a regulatory determination or endorsement.